- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
McKesson to Pay $151 Million to Settle Drug-Pricing Suit
McKesson Corp. will pay $151 million to 29 states over allegations the company artificially raised Medicaid drug prices for years, the latest settlement over claims the pharmacy supply chain overcharged for prescription medications.
McKesson, the nation's largest drug wholesaler by revenue, deliberately drove up the prices of some 1,400 brand-name drugs from 2001 to 2009, state and federal officials alleged in a lawsuit. Prices for some widely used blockbuster drugs, like Pfizer Inc.'s Lipitor or Eli Lilly & Co.'s Prozac, rose by as much as 25%, causing Medicaid programs to overpay by millions, state officials said.
Read the full story: http://tinyurl.com/bpjvts2
Source: The Wall Street Journal
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
